• No results found

Host-Virus Interactions in Asthma and Chronic Obstructive Pulmonary Disease

N/A
N/A
Protected

Academic year: 2021

Share "Host-Virus Interactions in Asthma and Chronic Obstructive Pulmonary Disease"

Copied!
1
0
0

Loading.... (view fulltext now)

Full text

(1)

DOCTORAL THESIS

SAHLGRENSKA ACADEMY

2018

Host-Virus Interactions in Asthma and Chronic

Obstructive Pulmonary Disease

Christopher McCrae

Christopher McCrae is a Team Leader and Principal Scientist in the Bioscience Department, IMED Respiratory Inflammation and Autoimmunity (RIA), AstraZeneca Gothenburg, Sweden.

Since graduating in 1999 with a BSc (Hons) in Molecular and Cellular Pathology from the University of Glasgow, UK, he has worked in various roles in drug discovery and early clinical phase drug development in the respiratory field at AstraZeneca in the UK and Sweden. He is an experienced translational science and biology lead on drug discovery and development programs. In addition, throughout his time at AstraZeneca he has conducted research to identify and validate novel targets and mechanisms involved lung host defense in asthma and chronic obstructive pulmonary disease (COPD), and has led several industry-academic collaborations in this area. He has recently accepted a position in MedImmune, Gaithersburg, USA as Principal Scientist in Translational Medicine, RIA, starting in late 2018.

Christopher’s long-standing research interest has been to investigate respiratory virus- host interactions in the airway epithelium and how those interactions determine risk of asthma and COPD exacerbations. In his doctoral thesis, he has identified and evaluated novel potential targets for the prevention of virus-triggered exacerbations.

Through functional genomic screening in rhinovirus-infected bronchial epithelial cells, he discovered an anti-viral effect of inhibiting lanosterol synthase, a component of the cholesterol biosynthetic pathway. In a phase 2 trial of inhaled inferferon ß-1a, he identified potential responder subgroups within the study cohort. Finally, in a Chinese cohort of COPD patients he demonstrated that levels of the anti-microbial peptide, beta defensin-2, are reduced in the airways of patients at risk of exacerbations as well as during viral exacerbations.

ISBN 978-91-7833-141-3 (PRINT) ISBN 978-91-7833-142-0 (PDF) Printed by BrandFactory, Gothenburg

Host-Virus Interactions in Asthma and Chronic Obstructive Pulmonary Disease | Christopher McCrae

SAHLGRENSKA ACADEMY

INSTITUTE OF MEDICINE

References

Related documents

Asthma and chronic obstructive pulmonary disease (COPD) are associated with periods of worsened symptoms, known as exacerbations.. Severe exac- erbations can result in

Asthma and chronic obstructive pulmonary disease (COPD) are associated with periods of worsened symp- toms, known as exacerbations.. Severe exacerbations can result in

The main findings in the present study are that in oxygen- dependent COPD 1) comorbidity differs between men and women, 2) comorbidity is an independent predictor of mortality

Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and Chronic Obstructive Pulmonary Disease: An Analysis From the Platelet Inhibition and Patient

Conclusion: Compared with the gold standard DLW method, the total daily energy expenditure can be assessed reliably by SenseWear Armband 5 in women with COPD, while other

In the validation study (Papers I-III), the strengths are: 1) this study is the first to assess TEE, energy intake and energy requirement exclusively in women with COPD; 2) the

Although smoking and age remained as important risk factors, the socioeconomic groups manual workers in industry, non-manual employees and self-employed other than

Measurements of lung function (spirometry) are required to diagnose COPD, and disease severity and progress of both asthma and COPD rely on spirometry, where observed